Maximum quantity allowed is 999
CAS RN: 93106-60-6 | Product Number: E0786
Enrofloxacin

Purity: >98.0%(T)(HPLC)
- 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹9,000.00
|
Contact Us | ≥100 |
|
25G |
₹16,000.00
|
2 | 25 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | E0786 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__2__2FN__3O__3 = 359.40 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 93106-60-6 |
Reaxys Registry Number | 5307824 |
PubChem Substance ID | 87560805 |
Merck Index (14) | 3592 |
MDL Number | MFCD00792463 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Melting point | 222.0 to 228.0 °C |
Melting Point | 225 °C |
RTECS# | VB1993650 |
References
- Pharmacokinetics of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-ethyl-1-piperazinyl)-3-quinoline-carboxylic acid (CFPQ) in turkeys.
- Veterinary Use of New Quinolones in Japan (a review)
- Fluoroquinolone-induced retinal degeneration in cats (a review)
- Enrofloxacin: Pharmacokinetics and Metabolism in Domestic Animal Species (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.